Entecavir Tablet, Film Coated
Product Images NDC 42291-261

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Entecavir (NDC 42291-261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

261 30 0.5mg Amneal

This is a description for a medication with the NDC 42291-261-30 number. Each tablet contains 0.5 mg of entecavi and it should be stored at 20 to 25°C (68 to 77F) in a tightly closed container protected from light. The tablets are manufactured by Amneal Pharmaceuticals of NY, LLC and should be taken following the dosage information and indications in the package insert.*

FDA Label Image

262 30 1mg Amneal

This is a description of a medication containing 1mg of entecavir per tablet. The medication is controlled and comes in a package insert that provides information about indications and dosage. The tablets should be stored at a temperature between 20 to 25C. The manufacturer is AKERE, located in TN, and the tablets are manufactured by Amneal Pharmaceuticals located in W Brookhaven, NY.*

FDA Label Image

Structural Formula (Entecavir Tablets 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.